Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours (Q44222422)
Jump to navigation
Jump to search
scientific article published in November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours |
scientific article published in November 2002 |
Statements
1 reference
Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours (English)
1 reference
A Awada
1 reference
F A L M Eskens
1 reference
M Piccart
1 reference
D L Cutler
1 reference
A van der Gaast
1 reference
H Bleiberg
1 reference
J Wanders
1 reference
M N Faber
1 reference
P Statkevich
1 reference
P Fumoleau
1 reference
J Verweij
1 reference
EORTC Early Clinical Studies Group
1 reference
1 November 2002
1 reference
1 reference
Identifiers
1 reference